360 related articles for article (PubMed ID: 10225557)
1. Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck.
Stausbøl-Grøn B; Overgaard J
Radiother Oncol; 1999 Jan; 50(1):47-55. PubMed ID: 10225557
[TBL] [Abstract][Full Text] [Related]
2. In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data.
Stausbøl-Grøn B; Bentzen SM; Jørgensen KE; Nielsen OS; Bundgaard T; Overgaard J
Br J Cancer; 1999 Mar; 79(7-8):1074-84. PubMed ID: 10098739
[TBL] [Abstract][Full Text] [Related]
3. Selective assessment of in vitro radiosensitivity of tumour cells and fibroblasts from single tumour biopsies using immunocytochemical identification of colonies in the soft agar clonogenic assay.
Stausbøl-Grøn B; Nielsen OS; Møller Bentzen S; Overgaard J
Radiother Oncol; 1995 Nov; 37(2):87-99. PubMed ID: 8747932
[TBL] [Abstract][Full Text] [Related]
4. Acute and late toxicity, tumour control and intrinsic radiosensitivity of primary fibroblasts in vitro of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.
Rudat V; Dietz A; Nollert J; Conradt C; Weber KJ; Flentje M; Wannenmacher M
Radiother Oncol; 1999 Dec; 53(3):233-45. PubMed ID: 10660204
[TBL] [Abstract][Full Text] [Related]
5. Characterization and radiosensitivity of fibroblasts derived from squamous cell carcinomas of the head and neck, and the surrounding oral mucosa.
Stausbøl-Grøn B; Bentzen SM; Overgaard J
Acta Oncol; 1998; 37(7-8):697-700. PubMed ID: 10050990
[TBL] [Abstract][Full Text] [Related]
6. The in vitro radiosensitivity of human head and neck cancers.
Björk-Eriksson T; West CM; Karlsson E; Slevin NJ; Davidson SE; James RD; Mercke C
Br J Cancer; 1998 Jun; 77(12):2371-5. PubMed ID: 9649161
[TBL] [Abstract][Full Text] [Related]
7. Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers.
Björk-Eriksson T; West C; Karlsson E; Mercke C
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):13-9. PubMed ID: 10656366
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitivity of dermal and tumor fibroblasts derived from the same patient.
Honkanen J; Rantanen V; Kulmala J; Grénman R; Klemi P; Pekkola K
J Cancer Res Clin Oncol; 1998; 124(8):415-20. PubMed ID: 9750017
[TBL] [Abstract][Full Text] [Related]
9. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer.
Nordsmark M; Overgaard J
Acta Oncol; 2004; 43(4):396-403. PubMed ID: 15303502
[TBL] [Abstract][Full Text] [Related]
10. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix.
West CM; Davidson SE; Roberts SA; Hunter RD
Br J Cancer; 1997; 76(9):1184-90. PubMed ID: 9365167
[TBL] [Abstract][Full Text] [Related]
11. In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: cell characterization and correlations with local control and overall survival.
Girinsky T; Bernheim A; Lubin R; Tavakoli-Razavi T; Baker F; Janot F; Wibault P; Cosset JM; Duvillard P; Duverger A
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):789-94. PubMed ID: 7960980
[TBL] [Abstract][Full Text] [Related]
12. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
13. Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual?
Haikonen J; Rantanen V; Pekkola K; Kulmala J; Grénman R
Int J Cancer; 2003 Mar; 103(6):784-8. PubMed ID: 12516099
[TBL] [Abstract][Full Text] [Related]
14. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
15. Time-dose-response relationships in postoperatively irradiated patients with head and neck squamous cell carcinomas.
Muriel VP; Tejada MR; de Dios Luna del Castillo J
Radiother Oncol; 2001 Aug; 60(2):137-45. PubMed ID: 11439208
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial.
Grau C; Prakash Agarwal J; Jabeen K; Rab Khan A; Abeyakoon S; Hadjieva T; Wahid I; Turkan S; Tatsuzaki H; Dinshaw KA; Overgaard J
Radiother Oncol; 2003 Apr; 67(1):17-26. PubMed ID: 12758236
[TBL] [Abstract][Full Text] [Related]
17. Biological predictors of radiosensitivity in head and neck squamous cell carcinoma.
Fiedler M; Weber F; Hautmann MG; Haubner F; Reichert TE; Klingelhöffer C; Schreml S; Meier JK; Hartmann A; Ettl T
Clin Oral Investig; 2018 Jan; 22(1):189-200. PubMed ID: 28315964
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
19. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
[TBL] [Abstract][Full Text] [Related]
20. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
